Personal CFO Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $506K | Sell |
|
|||||
|
2025
Q1 | $562K | Buy |
|
|||||
|
2024
Q4 | $430K | Buy |
|
|||||
|
2024
Q3 | $320K | Buy |
|
|||||
|
2024
Q2 | $311K | Sell |
|
|||||
|
2024
Q1 | $278K | Sell |
|
|||||
|
2023
Q4 | $402K | Sell |
|
|||||
|
2023
Q3 | $370K | Buy |
|
|||||
|
2023
Q2 | $274K | Sell |
|
|||||
|
2023
Q1 | $267K | Sell |
|
|||||
|
2022
Q4 | $274K | Buy |
|
|||||
|
2022
Q3 | $274K | Buy |
|
|||||
|
2022
Q2 | $266K | Sell |
|
|||||
|
2022
Q1 | $456K | Buy |
|
|||||
|
2021
Q4 | $203K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $288K | Buy |
|
|||||
|
2020
Q4 | $210K | Buy |
|
|||||
|
2020
Q3 | $0 | Buy |
|
|||||
|
2020
Q2 | $213K | Buy |
|